| Name | Title | Contact Details |
|---|
Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.
Synergy Vision is a Livermore, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HyGreen is a Gainesville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Exthera Medical is a Berkeley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Condensed Curriculum International Inc is a Fairfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.